This text is a result of machine translation.
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
4Paradigm Initiates IPO Today and Targets HKSE on September 28
Power Device Company Maplesemi Completes Series A+ Financing Round
Acoustic Technology Company Audfly Completes Series B Financing Round
Wicue Raised CNY 200 Mn in Series C+ Financing Round
Intelligent Industrial Drone and UAV Systems Developer I-KINGTEC Closed A Series C+ Financing Round
Em-Data Technology Completed Strategic Financing Round
Guiding Price of Huazhu Group is HKD 297/Share
Huazhu Group Plans to IPO in Hong Kong
Huazhu Groups' Revenue to Fall by 32%~34% YoY
Huazhu Group Records a CNY 2.14 Billion Loss in 2020Q1
Saudi Arabia's Vision 2030: Foreign Investment Bidding Landscape, Risks, and Opportunities
Oct 25, 2024 10:31 PM
Chinese tea beverages are experiencing a resurgence in Thailand
Oct 21, 2024 02:52 PM
How Can Solar Companies Seize Opportunities in the Post-Subsidy Era?
Oct 10, 2024 05:23 PM